{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+draw+and+questionnaires&page=2", "query": { "intervention": "Blood draw and questionnaires", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 1016, "total_pages": 102, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+draw+and+questionnaires&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+draw+and+questionnaires&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T03:09:20.860Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04044430", "title": "Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Colon Adenocarcinoma", "Metastatic Colorectal Adenocarcinoma", "Metastatic Microsatellite Stable Colorectal Carcinoma", "Metastatic Rectal Adenocarcinoma", "Stage III Colon Cancer", "Stage III Colorectal Cancer", "Stage III Rectal Cancer", "Stage IIIA Colon Cancer", "Stage IIIA Colorectal Cancer", "Stage IIIA Rectal Cancer", "Stage IIIB Colon Cancer", "Stage IIIB Colorectal Cancer", "Stage IIIB Rectal Cancer", "Stage IIIC Colon Cancer", "Stage IIIC Colorectal Cancer", "Stage IIIC Rectal Cancer", "Stage IV Colon Cancer", "Stage IV Colorectal Cancer", "Stage IV Rectal Cancer", "Stage IVA Colon Cancer", "Stage IVA Colorectal Cancer", "Stage IVA Rectal Cancer", "Stage IVB Colon Cancer", "Stage IVB Colorectal Cancer", "Stage IVB Rectal Cancer", "Stage IVC Colon Cancer", "Stage IVC Colorectal Cancer", "Stage IVC Rectal Cancer" ], "interventions": [ { "name": "Binimetinib", "type": "DRUG" }, { "name": "Encorafenib", "type": "DRUG" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2020-08-31", "completion_date": "2022-07-31", "has_results": false, "last_update_posted_date": "2023-01-09", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 2, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04044430" }, { "nct_id": "NCT05501366", "title": "Strategies to Augment Ketosis: Optimization of Ketone Delivery Strategies", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ketosis" ], "interventions": [ { "name": "Ketone Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage Tolerability Questionnaire (BTQ) and satiety visual analogue scale", "type": "BEHAVIORAL" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Breath Reading", "type": "OTHER" }, { "name": "Heart Rate Variability", "type": "OTHER" }, { "name": "CGM/CKM", "type": "OTHER" }, { "name": "DXA", "type": "RADIATION" }, { "name": "Urine Analysis", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "BEHAVIORAL", "BIOLOGICAL", "OTHER", "RADIATION" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "30 Years", "sex": "MALE", "summary": "20 Years to 30 Years · Male only" }, "enrollment_count": 14, "start_date": "2023-06-05", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05501366" }, { "nct_id": "NCT06764095", "title": "Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Locally Advanced Bladder Urothelial Carcinoma", "Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma", "Metastatic Bladder Urothelial Carcinoma", "Metastatic Renal Pelvis and Ureter Urothelial Carcinoma", "Stage III Bladder Cancer AJCC v8", "Stage IV Bladder Cancer AJCC v8", "Stage IV Renal Pelvis and Ureter Cancer AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cystectomy", "type": "PROCEDURE" }, { "name": "Enfortumab Vedotin", "type": "DRUG" }, { "name": "Local Therapy", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Ureterectomy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2025-01-08", "completion_date": "2034-12-31", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06764095" }, { "nct_id": "NCT06907550", "title": "Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "The Mitomic Endometriosis Test (MET) blood test for early detection of endometriosis", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Pearsanta, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 1000, "start_date": "2025-04", "completion_date": "2030-04", "has_results": false, "last_update_posted_date": "2025-04-13", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06907550" }, { "nct_id": "NCT02663271", "title": "TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glioblastoma Multiforme", "Glioblastoma", "Malignant Glioma", "GBM" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Optune", "type": "DEVICE" }, { "name": "Brain MRI", "type": "OTHER" }, { "name": "Quality of Life Questionnaires", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 10, "start_date": "2016-12-19", "completion_date": "2021-06-11", "has_results": true, "last_update_posted_date": "2022-06-23", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 2, "location_summary": "Gainesville, Florida • St Louis, Missouri", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02663271" }, { "nct_id": "NCT06450171", "title": "Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Predisposition Syndrome", "Predisposition, Genetic" ], "interventions": [ { "name": "GRAIL Galleri Test", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 1000, "start_date": "2024-09-27", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-01-20", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06450171" }, { "nct_id": "NCT05327608", "title": "Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anatomic Stage I Breast Cancer AJCC v8", "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "Invasive Breast Carcinoma" ], "interventions": [ { "name": "Short-Term Fasting", "type": "OTHER" }, { "name": "Chemotherapy", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DRUG", "PROCEDURE" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2022-07-28", "completion_date": "2027-05-01", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 5, "location_summary": "Cherry Hill, New Jersey • Sewell, New Jersey • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "Cherry Hill", "state": "New Jersey" }, { "city": "Sewell", "state": "New Jersey" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Willow Grove", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05327608" }, { "nct_id": "NCT03025763", "title": "Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Craniosynostosis" ], "interventions": [ { "name": "Craniosynostosis Network Environmental Survey", "type": "OTHER" }, { "name": "2D/3D Photography", "type": "OTHER" }, { "name": "Buccal Swab Cell Sampling", "type": "PROCEDURE" }, { "name": "Blood sampling", "type": "PROCEDURE" }, { "name": "Skin Biopsy", "type": "PROCEDURE" }, { "name": "Tissues from a Clinically Indicated Procedure", "type": "PROCEDURE" }, { "name": "Pre-operative CT Scan Image Files.", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "80 Years", "sex": "ALL", "summary": "Up to 80 Years" }, "enrollment_count": 2145, "start_date": "2015-01-13", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2025-01-02", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 15, "location_summary": "Davis, California • Hartford, Connecticut • Chicago, Illinois + 10 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03025763" }, { "nct_id": "NCT02144649", "title": "Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stage I Prostate Cancer", "Stage IIA Prostate Cancer", "Stage IIB Prostate Cancer", "Stage III Prostate Cancer", "Stage IV Prostate Cancer" ], "interventions": [ { "name": "dietary intervention (tangerine tomato juice)", "type": "DIETARY_SUPPLEMENT" }, { "name": "dietary intervention (red tomato juice)", "type": "DIETARY_SUPPLEMENT" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "Correlative studies", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "MALE", "summary": "21 Years and older · Male only" }, "enrollment_count": 45, "start_date": "2015-06", "completion_date": "2016-09-22", "has_results": false, "last_update_posted_date": "2019-08-30", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 2, "location_summary": "Columbus, Ohio • Dublin, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "Dublin", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02144649" }, { "nct_id": "NCT02123121", "title": "Resveratrol to Enhance Vitality and Vigor in Elders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mitochondrial Function", "Physical Function" ], "interventions": [ { "name": "Resveratrol 1000 mg/day", "type": "DRUG" }, { "name": "Resveratrol 1500 mg/day", "type": "DRUG" }, { "name": "Vegetable cellulose", "type": "OTHER" }, { "name": "All groups", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 60, "start_date": "2015-09", "completion_date": "2019-05-02", "has_results": true, "last_update_posted_date": "2024-04-26", "last_synced_at": "2026-10-01T03:09:20.860Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02123121" } ] }